Clinical Trial Update: Study of GS-4571 in Healthy Participants, Nondiabetic Obese Participants, and Nonobese Participants With Type 2 Diabetes Mellitus (T2DM) [Phase 1]

View source ↗

Summary

Phase 1 study to assess safety, tolerability, and pharmacokinetics of GS-4571 in healthy volunteers, obese individuals, and nonobese individuals with Type 2 Dia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• GS-4571

Snippet

Sponsor: Gilead Sciences | Conditions: Weight Management | Phase 1 | Status: RECRUITING